Philippe Calais is a director of TransCode Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Transcode Therapeutics, Inc.
19 May 23
4
Transcode Therapeutics, Inc.
10 May 23
4
Transcode Therapeutics, Inc.
22 Jun 22
3
Transcode Therapeutics, Inc.
8 Jul 21
4
CohBar, Inc.
4 Jun 19
4
CohBar, Inc.
10 Dec 18
4
CohBar, Inc.
7 Jun 18
3
CohBar, Inc.
7 Jun 18
4
Marina Biotech, Inc.
4 May 18
4
Marina Biotech, Inc.
3 Jan 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 May 23 | RNAZ TransCode Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.2834 | 45,000 | 12.75 k | 45,000 |
10 May 23 | RNAZ TransCode Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.2985 | 9,500 | 2.84 k | 9,500 |